The tumor cell environment may in¯uence drug response through interactions with the extracellular matrix (ECM). We recently reported that adhesion of myeloma cells to ®bronectin (FN) via b1 integrins is associated with a cell adhesion mediated drug resistance (CAM-DR). Activation of b1 integrins is known to in¯uence both apoptosis and cell growth. We hypothesized that the FN mediated cytoprotection may be in part due to perturbations in cell cycle progression. In this report we demonstrate that adhesion of myeloma cells to FN results in a G 1 arrest associated with increased p27 kip1 protein levels and inhibition of cyclin A and E associated kinase activity. Disruption of cells from FN adhesion resulted in a rapid recruitment of cells into S phase, a decrease in p27 kip1 levels, and reversion to a drug sensitive phenotype. Treatment of cells with p27
Kip1 antisense oligonucleotides did not aect FN adhesion; however, p27
Kip1 protein levels were reduced and cells became sensitive to cytotoxic drugs. These studies demonstrate that b1 mediated adhesion of myeloma cells to FN regulates p27 kip1 levels and that p27 kip1 levels are causally related to CAM-DR. Disruption of b1 integrin mediated FN adhesion may represent a potential target for the potentiation of drug induced apoptosis. Oncogene (2000) Introduction Myeloma is a disease that typically demonstrates a low proliferative rate and ultimately becomes resistant to chemotherapy. A major factor believed to contribute to the pathogenesis of this disease is a block in programmed cell death. This aberration in programmed cell death may also contribute to the problem of drug resistance. Myeloma cells home to the bone marrow, suggesting that the bone marrow microenvironment provides components necessary for growth and survival of tumor cells. The bone marrow microenvironment consists of hematopoietic cells, stromal cells and extracellular matrix (ECM) . Interactions between the tumor cell and components of the microenvironment could alter drug response by blocking apoptosis. Our laboratory recently reported that adhesion of myeloma cell lines to ®bronectin (FN), a component of the ECM, protects cells from apoptosis initiated by DNA damaging drugs including anthracyclines and alkylating agents (Damiano et al., 1999) . In this report, we provide mechanistic data showing that adhesion to FN increased p27 kip1 protein levels and that the increase in p27 kip1 protein levels is causally related to the induction of the CAM-DR phenotype.
Myeloma cell lines typically express the b1 integrins VLA-4 (a4b1) and VLA-5 (a5b1) (Damiano et al., 1999; Cook et al., 1996; Jensen et al., 1993) . Adhesion via b1 integrins has been shown to regulate cellular growth, dierentiation, and survival (Bohnsack and Chang, 1994; Giancotti and Ruoslahti, 1990; Lin and Bissel, 1993; Zhang et al., 1995) . Depending on the cellular context, activation of b1 integrins can transduce either positive or negative growth signals (Giancotti and Ruoslahti, 1990; Fornaro et al., 1995; Lundell et al., 1996; Meredith et al., 1995; Hurley et al., 1995; Pozzi et al., 1998; Wary et al., 1996) . b1 integrins activate multiple signal transduction pathways including FAK (Hanks et al., 1992) , MAPK (Lin et al., 1997) , Src family kinase, PI3 kinase (Meng and Lowell, 1998) and AKT (Lee and Juliano, 2000; King et al., 1997) . Activating these pathways in epithelial cells is associated with increased cellular proliferation and survival. However, several reports demonstrated that activation of b1 integrins in hematopoietic cells continues to provide a survival signal, but is also associated with inhibition of cell growth (Hurley et al., 1995 (Hurley et al., , 1997 Lundell et al., 1996; Wang et al., 1998) . We hypothesized that b1 integrin activation in the myeloma cell line RPMI 8226 may induce a growth arrest and contribute to the CAM-DR phenotype observed in this cell line.
The ecacy of certain anticancer agents may be reduced when cells exit the cell cycle (Solary et al., 1993) . Accumulating evidence shows that the cyclin dependent kinase inhibitors p21 and p27 kip1 negatively regulate cell growth and may represent a new class of drug resistance genes (Coats et al., 1996; Erhardt and Pittman, 1998; Ruan et al., 1998; Eymin et al., 1999) . Experimental evidence to support this concept includes reports where the ectopic expression of either p21 or p27 kip1 caused resistance to DNA damaging drugs (Ruan et al., 1998; Eymin et al., 1999) . Therefore, the activation of cell signaling pathways that increase the levels of p21 and/or p27 kip1 may result in drug resistance and increased survival of tumor cells. St. Croix et al. (1996) recently demonstrated that when cells are grown as a spheroid culture, the p27 kip1 protein levels are increased compared to monolayer cultures. This increase in p27 kip1 correlated with a G 1 arrest and resistance to alkylating agents. Although the introduc-tion of p27 kip1 antisense reversed drug resistance, it is currently unknown what cell surface molecule(s) and signaling pathway(s) are responsible for elevated levels of p27
Kip1
. Recent evidence showed that transfection of either E-cadherin or N-cadherin can mediate contactdependent growth inhibition of EMT/6 and CHO-K1 cells respectively (St Croix et al., 1998; Levenberg et al., 1999) . Like non-transformed cells, the contact inhibition associated with the transfection of the cell adhesion molecules E-cadherin or N-cadherin in these cancer cell lines correlated with increased p27 Kip1 protein levels. Together, these data suggest that cancer cell lines contain the appropriate intracellular signals for the regulation of p27
Kip1 protein levels. Furthermore, activation of speci®c cell adhesion molecules may be integral in transducing signals that regulate p27
Kip1 protein levels in tumor cells resulting in the inhibition of drug induced apoptosis.
In this report, we demonstrate that adhesion of RPMI 8226 cells to FN resulted in a drug resistant phenotype associated with a reversible growth arrest, elevated p27
Kip1 protein levels and inhibition of cyclin A and E associated kinase activity. Disruption of cellular adhesion to FN reversed resistance to drug induced apoptosis, suggesting that signaling through b1 integrins is responsible for CAM-DR. Reducing p27
protein levels with p27
antisense reversed drug resistance, implicating p27
Kip1 as a downstream eector of b1 integrin signaling and development of CAM-DR.
Results

Binding to FN via b1 integrins induces a reversible growth arrest
Cellular binding to FN can be mediated by several integrin receptors including a4b1, a5b1, a4b7 and avb3. As shown in Figure 1 , adhesion of 8226 cells to FN is mediated by both a4 and a5 integrins. In the presence of the b1 blocking antibody, adhesion to FN is reduced to levels observed for BSA binding. These results indicate that b1 integrin receptors are required for adhesion of RPMI 8226 cells to FN.
As shown in Figure 2a , inhibition of DNA synthesis, as measured by 3 H-thymidine incorporation, was detected soon after adherence to FN. The inhibition of DNA synthesis persisted for 72 h. BrdU-PI incorporation was performed to determine whether the inhibition of cell growth was accompanied by accumulation of cells in a speci®c phase of the cell cycle. Following 48 h of adhesion, we observed 29% more cells residing in G 1 compared to cells in suspension (n=4 independent experiments P50.01 by Student's t-test). The increase in the number of cells in G 1 correlated with 26% fewer cells actively incorporating the nucleotide analog BrdU (see Figure 2b ). To determine if the growth arrest initiated by adhesion to FN was reversible, cells were detached following a 48 h FN adhesion and then grown in suspension for the indicated times prior to pulsing with BrdU for 1 h. As shown in Figure 2c , disruption of adhesion to FN resulted in the rapid incorporation of BrdU. This indicates that adhesion to FN does not induce terminal growth arrest in 8226 cells and that the adherent population appears to accumulate at the G 1 /S interphase.
Adhesion to FN via b1 integrins reversibly induces p27
Kip1 protein levels
Cell cycle progression is driven by the sequential activation of cyclin dependent kinases (CDK's) which form complexes with speci®c activating subunits referred to as cyclins. Figure 2c illustrates how cells attached to FN appear to accumulate at the G 1 /S border. Evidence suggests that the cyclin E-Cdk2 and cyclin A-Cdk2 complexes regulate the G 1 /S transition (Girard et al., 1991; Ohtsubo et al., 1995) . The CDK inhibitors p21 and p27
Kip1 block the kinase activity of cyclin E-cdk2 and cyclin A-cdk2 complexes (Toyoshima and Hunter, 1994; Polyak et al., 1994a,b) . When RPMI 8226 cells were placed in culture attached to FN a rapid and persistent increase in p27
Kip1 levels was observed (see Figure 3a) . The 40 ± 60% increase in p27 Kip1 protein levels persisted for at least 24 h following adhesion to FN. To determine if the increase in p27
Kip1 levels was reversible, cells were ®rst adhered to FN for 48 h, then detached with 5 mM EDTA and grown in suspension for the indicated times. Following detachment from FN, p27
Kip1 levels were reduced by 84%. This indicates that disruption of FN mediated adhesion resulted in a rapid decrease in p27
Kip1 (see Figure 3b ). These ®ndings were consistent with the rapid onset of DNA synthesis following disruption of FN adhesion (Figure 2c ). In contrast to p27
Kip1
, p21 protein levels were undetectable from lysates obtained from cells grown in suspension or adhered to FN (data not shown).
A multiprobe RNase protection assay was used to determine if adhesion to FN increased p27
Kip1 mRNA. As shown in Figure 3c , we did not detect increases in the RNA levels of p27
Kip1 or any other known CDK inhibitors following adhesion of cells to FN. Together, these data indicate that adhesion of RPMI 8226 cells to FN results in alteration(s) in post-transcriptional 
Adhesion of cells to FN inhibits cyclin A and E associated kinase activity
Regulation of the G1/S interphase is regulated by cyclin E and A dependent CDK2 kinase. Kinase assays were performed to determine whether adhesion of cells to FN inhibited the kinase activity associated with cyclin A and/or cyclin E. Cyclin E, A,D3 and CDK2 immunoprecipitates from cells maintained in suspension or adhered to FN for 48 h were assayed for kinase activity as measured by phosphorylation of either histone H1 or GST-RB. Adhesion of RPMI 8226 cells to FN for 48 h resulted in a 52, 55 and 43% (n=3 independent experiments at least) reduction in cyclin A and E associated and total CDK2 kinase activity respectively, compared to cells grown in suspension (see Figure 4a ). These data are consistent with a late G1-early S phase block in cell cycle progression. The diminished CDK2 kinase activity could not be attributed to decreased cyclin A or E protein expression (see Figure 4b ), suggesting that increased p27 levels may be inhibiting cyclin dependent CDK2 kinase activity. Cyclin D3 associated kinase activity was measured by the phophorylation of GST-RB. We did not observe any signi®cant alterations in cyclin D3 associated kinase activity (see Figure 4c ) and the levels of cyclin D1 were undetectable from cell lysates obtained from either suspension or FN adhered cells (data not shown). This data is consistent with previous reports indicating that p27kip1 is a more potent inhibitor of cyclin E-CDK2 activity compared to cyclin D-CDK4 activity (Polyak et al., 1994a) .
CAM-DR phenotype correlates with reversible p27
Kip1 levels and growth arrest
To address the question of whether drug resistance associated with FN adhesion is reversible, cells were detached from FN following 48 h of adhesion and grown in suspension for 8 h prior to drug treatment. Apoptosis was detected by Annexin V positive staining as previously described. As shown in Figure 5 , cells that were continuously adhered to FN showed only a 6% drug induced apoptosis compared to 30% for cells exposed to the drug while in suspension (P50.01 by Student's t-test). In contrast, cells that were adhered to FN for 48 h and then detached and placed in suspension media for 8 h prior to drug exposure had a mean value of 22% apoptotic cells compared to the 6% apoptotic cells observed for continuously adherent cells (P50.01 by Student's t-Test). These results demonstrate that the anti-apoptotic eect associated with FN adhesion is reversible and correlates with p27
Kip1 protein levels.
Inhibition of p27
Kip1 protein levels partially reverses CAM-DR but does not inhibit adhesion to FN
A p27
Kip1 antisense strategy was used to determine if the increase in p27
Kip1 directly contributed to the CAM-DR phenotype. The propyne modi®ed oligonucleotide p27
Kip1 antisense sequence (see Materials and methods) was previously reported to eectively inhibit p27 Kip1 protein levels (Hauser et al., 1999; Coats et al., 1996) . In our system, treatment of 8226 cells with 30 nM antisense caused a 75% mean (range 40 ± 98% n=4 independent experiments) reduction in p27
Kip1 protein levels compared to the mismatch control treated cells (see Figure 6a) . In the spheroid model reported by St.
Croix et al. inhibition of p27
Kip1 protein levels reduced adhesive cell-cell interaction. However, the adhesive moiety aected by the reduction of p27
Kip1 was not identi®ed. In our study, reducing p27
Kip1 protein levels by using p27
Kip1 antisense did not inhibit adhesion of 8226 cells to FN via b1 integrins (see Figure 6b) .
In spite of no observable eect on FN adhesion, treatment of cells with p27
Kip1
antisense reduced p27
Kip1 levels and increased VP-16 speci®c induced apoptosis (see Figure 6c) . Treatment of FN adhered cells with p27
Kip1 antisense oligonucleotides increased VP-16 induced apoptosis to 22%, compared to 8.8% for cells treated with mismatch oligonucleotides (P50.05 by Student's t-test, n=5 independent experiments performed in duplicate). These data support the hypothesis that increased p27
Kip1 protein levels induced by adhesion to FN contributes to CAM-DR.
Discussion
The tumor microenvironment has been previously reported to impact drug sensitivity and confer resistance to DNA damaging agents (Durand and Sutherland, 1972; Teicher et al., 1990; St Croix et al., 1996; Damiano et al., 1999; Sethi et al., 1999) . The ®rst model to demonstrate this was a spheroid cell culture model that more closely mimics the three-dimensional shape found for solid tumors (Durand and Sutherland, 1972) . This model clearly showed that the cell's position within the spheroid altered its sensitivity to drugs and radiation. The implication of this observation was that cell ± cell contacts might alter drug and radiation response. Further evidence supporting the concept that cell ± cell interactions can limit the ecacy of chemotherapeutic drugs was provided by Teicher et al. (1990) . This report showed that the in-vivo selection for resistance to alkylating agents resulted in a resistance mechanism detected only in vivo, suggesting that the host-tumor cell interaction contributed to the drug-resistant phenotype. We previously reported that adhesion of myeloma cell lines to FN conferred resistance to DNA-damaging agents (Damiano et al., 1999; Damiano and Dalton, 2000) . In our model, myeloma tumor cells are grown as a monolayer attached to FN. This allows investigations of cell matrix interactions without the concern of hypoxia or drug and nutrient deprivation contributing to the drug resistant phenotype. This system also allows us to Similar to our ®ndings for myeloma cells, Sethi et al. (1999) recently reported that binding of small cell lung cancer cell lines to FN via b1 integrins conferred resistance to DNA damaging drugs. Furthermore Hoyt et al. (1996) demonstrated that adhesion to ®bronectin protected tumor-derived endothelial cells from VP-16 induced double-strand breaks suggesting that adhesion could also protect cells responsible for the vascularization of the tumor. Collectively, these data indicate that b1 integrins may represent a cell surface pathway capable of protecting cells from drug induced cytotoxicity. To our knowledge, this is the ®rst report to demonstrate a mechanism by which cellular adhesion via b1 integrins is able to confer drug resistance or CAM-DR.
In this report we showed that adhesion to FN caused a reversible growth arrest that correlated with p27 Kip1 protein levels. The CAM-DR phenotype was reversible upon detachment of cells from FN, suggesting that reversal of the resistant phenotype may be related to a reduction in p27
Kip1
. A p27
Kip1 antisense strategy was employed to determine if a causal relationship existed between FN adhesion, p27
Kip1 levels, and drug sensitivity. The antisense approach successfully reduced p27
Kip1 protein levels, and drug sensitivity was restored in spite of no alterations in cell adhesion. Our studies utilizing the antisense approach indicate that increased p27
Kip1 protein levels resulting from b1 integrin FN adhesion are causative for the CAM-DR phenotype. The fact that p27
Kip1 antisense did not alter FN adhesion indicates that p27
Kip1 does not modify insideout activation of b1 integrins, and that the molecular target of p27
Kip1 is downstream from the b1 integrin receptor.
Although adhesion of 8226 myeloma cells to FN resulted in a rapid and reversible induction of p27 Kip1 protein levels, we did not observe any increases in p27
Kip1 mRNA levels. This indicates that increases in p27
Kip1 result from post-transcriptional regulation. It has been previously shown that the half-life of p27 Kip1 levels is increased in quiescent cells relative to proliferating cells, and that the increase in stability was shown to correlate with a decrease in ubiquination of p27 kip1 . Recent evidence showed that the phosphorylation of p27 kip1 targets the protein for degradation via the ubiquitin-proteosome pathway (Montagnoli et al., 1999) . Increase in p27 kip1 protein levels may also result from adhesion of cells to FN increasing the translational regulation of p27 (Agrawal et al., 1996) . Further studies are needed to determine if the FN-b1 integrin induced increase in p27 kip1 protein levels results from increased protein stability and/or increased synthesis of p27 kip1 . Depending on the cellular context, adhesion is reported to either negatively or positively regulate cell growth (KraÈ mer et al., 1999; Hurley et al., 1995 Hurley et al., , 1997 Zhu et al., 1996; Lundell et al., 1996; Jiang et al., 2000) . Recent evidence shows that cellular adhesion of ®broblasts is necessary for the progression past the G1 restriction point (Orend et al., 1998; Zhu et al., 1996) . These investigators demonstrated that ®broblast adhesion results in increased cyclin E and cyclin D1 dependent kinase activity. In contrast, adhesion of 8226 cells to FN resulted in growth arrest. The inhibition of cell growth correlated with reduced cyclin A and E-CDK2 dependent kinase activity. Inhibition of cyclin dependent CDK2 kinase activity could not be attributed to decreased cyclin A or E protein levels. This suggests that increased p27 kip1 protein levels may be inhibiting cyclin A and E dependent CDK2 kinase activity.
Previous reports showed that overexpression of the b1 splice variants, b1C or b1D is associated with inhibition of cell cycle progression (Fornaro et al., 1999; Meredith et al., 1995; Belkin and Retta, 1998) . Thus it is currently uncertain if adhesion-mediated dierences in response to cell growth is the result of deferential expression of integrin splice variants or divergent downstream signaling mediators. We are currently investigating the expression of splice variants in myeloma cell lines and patient samples.
The overexpression of p27 kip1 has been reported to protect cells from apoptosis induced by chemotherapeutic drugs (Eymin et al., 1999; Naumann et al., 1999) . However, in some cell lines, overexpression of p27 kip1 is associated with the induction of apoptosis (Katayose et al., 1997) . It is currently unclear if the apparent opposing physiological roles of p27 kip1 is cell type speci®c or related to the quantity of p27 kip1 expressed. Consistent with the role of p27 kip1 as a tumor suppressor gene, several clinical studies have indicated that low levels of p27 kip1 expression correlates with poor prognostic markers including increased metastasis, decreased disease-free survival and increased tumor growth rates (Kudo et al., 2000; Liu et al., 1999; Budel et al., 2000) . However, these studies have not correlated p27 kip1 levels with initial response to chemotherapy. Together these data suggest that, transient downregulation of p27 kip1 prior to treatment with cyctotoxic agents may have a therapeutic bene®t whereas chronic downregulation of p27 kip1 would adversely aect patient survival.
It remains uncertain what pathways and targets are aected by p27 kip1 resulting in blocking apoptosis. However, recent evidence shows that inhibition of Cdk2 kinase may result in an anti-apoptotic response (Hiromura et al., 1999; Hakem et al., 1999) . Hiromura et al. (1999) demonstrated that the serum starvation of p27 kip1 knockout ®broblast and mesangial cells resulted in a signi®cant increase in apoptosis compared to the wild type cells. The increase in apoptosis observed in the p27 kip1 knockout cells correlated with an increase in cyclin A-CDK2 activity, but not cyclin E-CDK2 kinase activity. The increase in apoptosis observed in serum starved p27 (7/7) cells could be reversed by either the pharmacological inhibition of Cdk2 or by expressing a dominant negative Cdk2. Further evidence supporting the role of Cdk2 regulating apoptosis was reported by Hakem et al. (1999) who demonstrated that the pharmacological inhibition of Cdk2 prevented thymocytes from undergoing apoptosis initiated by dexamethasone, FAS (CD95) or gamma radiation. However, the downstream target for Cdk2 that alters apoptotic response has yet to be identi®ed.
Another intriguing possibility is that binding of p27 kip1 to speci®c CDK complexes alters the substrate speci®city of downstream targets resulting in the inhibition of apoptosis. Recently, Dong et al. (1998) reported that a ternary complex, containing cyclin D3, p27
kip1 and CDK4 altered substrate speci®city compared to a binary complex containing cyclin D3 and CDK4. These investigators provided experimental evidence that the binding of p27 kip1 to speci®c CDK complexes can potentially alter the putative downstream targets of CDK's.
In summary, b1 integrins, when activated by FN adhesion, represent a novel cell surface molecule that can potentially regulate p27 kip1 protein levels and prevent drug-induced apoptosis. Myeloma cells derived from patient samples have been reported to express b1 integrins (Cook et al., 1996; Jensen et al., 1993) . Importantly, myeloma cells typically reside in the bone marrow where potential interaction with components of the ECM can occur. Thus we propose that myeloma cells which are adhered to FN via b1 integrins contain elevated levels of p27
kip1
. The elevated levels of p27 kip1 could potentially be causative for resistance to DNA damaging agents and other treatment modalities for hematopoietic tumors that express functional b1 integrins.
Materials and methods
Cell Culture
The RPMI 8226 human myeloma cell line was obtained from the American Type Culture Collection (Rockville, MD, USA). The cells were grown in suspension in RPMI 1640 (Cellgro, Fischer Scienti®c Pittsburgh, PA, USA), supplemented with 5% fetal bovine serum (Omega Scienti®c, Turzana CA, USA), and 1% (v/v) penicillin (100 U/ml), streptomycin (100 U/ml) and 1% (v/v) L-glutamine (GIB-CO ± BRL, Grand Island, NY, USA). Cells were maintained at 378C in 5% CO 2 /95% air atmosphere and were passaged once every 6 days.
Drugs and antibodies
Etoposide (VP-16) was obtained from Sigma (St Louis, MO, USA) and was dissolved in dimethylsulfoxide (DMSO). For apoptosis assays, the ®nal concentration of VP-16 was 5 mM and the ®nal DMSO concentration was 0.01%. Integrin antibodies used in these studies included a4 blocking antibody (P4G9, Dako, Carpinteria, CA, USA), a5 blocking antibody (P1D6, Dako) and b1 blocking antibody (P4C10, GIBCO ± BRL, Grand Island, NY, USA). A Monoclonal antibody to p27 Kip1 was obtained form Transduction Laboratory (Lexington, KY, USA). Cyclin A (H432) and cyclin D3 polyclonal antibodies were purchased from Santa Cruz Laboratory (Santa Cruz, CA, USA). Cyclin E and CDK2 polyclonal antibodies were purchased from Upstate Biotechnology (Waltham, MA, USA)
Adhesion assay
The following assay was used to determine the speci®city of adhesion of RPMI 8226 cells to soluble ®bronectin (FN). 96-well Immunosorp (Nunc, Denmark) plates were coated with either 50 ml (40 mg/ml) of soluble FN (Gibco) or bovine serum albumin (BSA) and allowed to evaporate overnight. Cells were washed once in serum-free RPMI media and then resuspended at a density of 1610 6 cells per ml. Prior to adhesion, cells were incubated for 30 min with a 1 : 100 dilution of either isotype control, a4 blocking antibody (P4G9), a5 blocking antibody (P1D6) or the b1 blocking antibody (P4C10). Following incubation with antibodies, 1610 5 cells were added to each well. After 1 h of adhesion, unattached cells were removed by washing three times with serum free RPMI media. The adherent cells were ®xed with 70% methanol for 10 min, dried and subsequently stained with a 0.02% crystal violet/0.2% ethanol solution. The stained cells were solubilized in 100 ml Sorenson solution and absorbance was read at 540 nm with an automated 96 well plate reader (Dynex, Chantilly, VA, USA).
Analysis of DNA synthesis
To examine the eects of FN adhesion on DNA synthesis, a tritiated thymidine incorporation assay was performed. 96-well immunosorp plates were coated with FN as previously described. Forty-thousand cells per well were added to FN coated wells for 2 h. Following 2 h of adhesion in serum-free media, unattached cells were removed with three washes in media containing 5% FBS. The suspension population was also incubated in serum-free media for 2 h and subsequently plated at a density of 8000 cells/well in RPMI media containing 5% FBS. At indicated times, 1 mCi 3 H-thymidine/well was added for 3 h. After the 3 h incubation, DNA was collected on a ®lter with a Tomtec (Hamden, CT, USA) cell harvester and incorporated 3 H-thymidine was detected by a Wallac (Gaithersburg, MD, USA) beta counter. Each experimental condition was performed in quadruplicate wells.
Cell cycle analysis
The eects of FN adhesion on cell cycle progression were measured by a two-color¯ow cytometry method, where S phase was detected by FITC conjugated anti-BrdU antibody and G 1 and G2-M populations were identi®ed by PI staining of DNA content. Approximately 1.25610 6 8226 cells were attached to each 60 mM FN coated plates as previously described. Suspension cells were plated at the same initial density as FN samples. Following 48 h of culture, 30 mg/ml bromodeoxyuridine (BrdU, Sigma) was added for 1 h. For the FN samples, unattached cells were removed by three sequential gentle washes with RPMI media, followed by incubation with 5 mM EDTA in PBS to remove adhered cells. Following incubation with BrdU, cells were ®xed with 66% cold ethanol. One million cells per sample were digested with 4 mls of a 0.04% pepsin solution containing 0.1% HCl for 1 h at 378C. Nuclei were centrifuged and then incubated in a 2 N HCl solution at 378C for an additional 30 min. Following acid denaturation of DNA, samples were washed once in 0.1 M sodium borate and once in PBTB (PBS containing 0.0025% Tween 20 and 0.5% BSA) then, resuspended in 200 ml PBTB and incubated with 5 ml of anti-BrdU FITC-conjugated antibody (Dako, Carpinteria, CA, USA) for 60 min in the dark. Samples were subsequently washed once in PBTB and resuspended in 500 ml of PBTB containing 10 mg/ml propidium iodide and 25 ml of 10 mg/ml Rnase A (Boehringer Mannheim, IN, USA). Following a 30 min incubation at 378C, samples were analysed for BrdU incorporation and propidium iodide staining and 10 000 events were analysed by¯ow cytometry (Becton Dickinson, San Jose, CA, USA).
RNA expression levels
RNA expression levels of cyclin dependent kinase inhibitors, including p27
Kip1
, were measured by an RNase protection assay. RNA was isolated from 8226 cells using Trizol reagent following adherence to FN for the indicated times. RNase protection assay was performed using the Pharmingen RiboQuant cell cycle kit according to manufacturer's protocol (Pharmingen, San Diego, CA, USA). The multiprobe template was prepared by 32 P incorporation in an in vitro transcription reaction, and free nucleotide was removed on a G50 column. Puri®ed probe (1610 6 c.p.m. speci®c activity) was combined with 20 mg of total RNA. The hybridization reaction was carried out overnight at 568C. Samples were treated with RNase for 45 min at 308C and then with proteinase K for 15 min at 378C. Hybridized probes were extracted with phenol : chloroform:isoamyl alcohol and precipitated using ethanol. Samples were separated on a 5% denaturing gel (7 mM urea) and protected fragments were quanti®ed by phosphor imaging analysis using Image Quant software (Molecular Dynamics, Sunnyvale, CA, USA).
Analysis of p27
kip1 , cyclin E and cyclin A protein levels
The eect of FN adhesion on p27
kip1
, cyclin A and cyclin E protein levels was determined by Western blot analysis. One million cells per ml were plated in 60 mm FN coated Nunc plates. Cells were allowed to adhere for 2 h in serum-free media, and unattached cells were removed with two washes in media containing 5% FBS. At indicated times, cells were washed three times in serum-free RPMI media to remove unattached cells with the ®nal wash using ice-cold PBS. After removal of unattached cells, 200 ml of lysis buer containing 50 mM HEPES pH 7.4, 150 mM NaCl, 0.1% Tween-20, 2 mM EDTA, 2 mM EGTA, 1 mM NaF, 0.1 mM NaVO 4 , 5 ug/ml leupeptin, 0.2 mM PMSF and 1 mM dithiotreitol (lysis buer). Following 30 min of incubation on ice, the lysates were centrifuged at 12 000 g for 15 min at 48C. The supernatant was collected and cell extracts were quanti®ed by BCA protein assay (Peirce, Rockford, IL, USA). Fifty microgram of whole cell lysate was dissolved in Laemmli SDS ± PAGE sample buer prior to separation by a 12% SDS ± PAGE for detection of the band of interest. Proteins were transferred to polyvinylidene (PVDF) membrane, probed with either a p27 kip1 monoclonal antibody or a cyclin A, or cyclin E, polyclonal antibody. The band of interest was detected by chemiluminescence (NEN, Boston, MA, USA). The blot was subsequently stripped (100 mM betamercaptoethanol, 2% SDS 62.5 mM Tris pH 6.7 for 30 min at 508C) and reprobed for b-actin (Sigma, St Louis, MO, USA). Protein bands were quanti®ed by the Image Quant software program (Molecular Dynamics, Sunnyvale, CA, USA).
Cyclin associated kinase activity
To determine whether the increase in p27 kip1 correlated with inhibition of CDK2 and or CDK4 activity, cyclin A, E, and D3 associated kinase activity and total CDK2 kinase activities were measured. Following 48 h of incubation, cells in suspension or adhered to FN were washed once in ice cold PBS and then lysed in buer containing 50 mM HEPES pH 7.4, 150 mM NaCl, 0.1% Tween-20, 2 mM EDTA, 2 mM EGTA, 1 mM NaF, 0.1 mM NaVO 4 , 5 ug/ml leupeptin, 0.2 mM PMSF and 1 mM dithiotreitol (lysis buer). Following 30 min of incubation on ice, the lysates were centrifuged at 12 000 g for 15 min at 48C. One-hundred ug of cell lysate was incubated with either 4 ml of cyclin A, E, D3 or CDK2 rabbit polyclonal antibody (for 2 ± 4 h). Immunoprecipitates were bound to protein A/G agarose and washed three times with lysis buer and once with kinase buer (50 mM HEPES pH 7.4, 10 mM MgCl 2 , 5 mM MnCl 2 and 1 mM dithiotreitol). Pellets were then incubated in 30 ml of kinase buer containing 20 uM ATP, 0.1 mCi/ml [g
32
-P]ATP, and either 100 mg/ml histone H1 (Boehringer Mannheim) or 100 mg/ml RB-GST fusion protein (Santa Cruz) for either 5 min for cyclin A and CDK2 or 25 min for cyclin D3 and E at 308C. Reactions were halted by adding 10 ml of 66Laemmli buer and boiling the samples for 3 min. The proteins were separated on a 12% SDS ± PAGE. The phosphorylation of histone H1 (Roche Molecular Biochemicals, Indianapolis, IN, USA) or GST-RB (Santa Cruz) was visualized by autoradiography.
Analysis of apoptosis
As previously described, a¯ow cytometric assay measuring Annexin V staining was used to measure apoptotic cells following drug exposure (Damiano et al., 1999) . FN coated plates were manufactured by using 35-mm Nunc tissue culture plates to which 1 ml of 40 ug/ml FN was added and allowed to evaporate overnight. One million cells resuspended in serum free media were attached to FN coated plates for 2 h. The cells were then gently washed once with one ml of RPMI media containing 5% FBS. Cells were allowed to adhere to FN for 48 h and unattached cells were removed by three sequential gentle washes in RPMI media containing 5% FBS. In some cases, cells were detached from FN using 5 mM EDTA in PBS. These cells were then washed three times with 25 mls of RPMI containing 5% FBS. After the ®nal wash the samples were resuspened in 1 ml RPMI media containing 5% FBS and cultured for an additional 8 h in a 35-mm uncoated Nunc culture dish. Drug induced apoptosis following exposure to VP-16 was measured in 8226 myeloma cells when cells were in suspension, attached to FN, or following release from FN adhesion. Either VP-16 (5 mM) or 0.01% DMSO was added to cells for 24 h. Following 24 h of drug exposure, apoptotic cells were detected using Annexin V staining and FCM analysis. Ten-thousand events were analysed by¯ow cytometry (Becton Dickinson, San Jose, CA, USA) and at least ®ve independent experiments were performed.
p27
Kip1 antisense experiments Cells were washed once in serum-free media and then resuspended at 1 million cells per ml in serum free RPMI media containing 2.5 mg/ml of the cationic lipid GS3815 (Gilead, Foster City, CA, USA) and either 30 nM of the C-5 propyne p27 kip1 antisense (5'-UGG CUC UCC UGC GCC) or 30 nM of the mismatch oligo (5'-UCC CUU UGG CGC GCC) (Gilead, Foster, CA, USA). The oligo-cell suspension was incubated in suspension for 2 h prior to adhesion to FNcoated plates for 2 h. Following 2 h of adhesion unattached cells were removed with three washes and the lipid-oligo mixture in RPMI containing 5% FBS was re-added to each plate. After 48 h of adhesion, unattached cells were removed from the plates with three washes. Cells that were exposed to either p27 kip1 antisense or mismatch lipid-oligo mixtures were then analysed for p27 kip1 protein levels, per cent adhesion and drug-induced apoptosis as previously described.
